Document Type

Article

Journal/Book Title/Conference

Emerging Infectious Diseases

Volume

24

Issue

9

Publisher

CDC

Publication Date

7-31-2018

First Page

1696

Last Page

1699

DOI

https://doi.org/10.3201/eid2409.180233

Abstract

Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus–viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.